NCT06782477View on ClinicalTrials.gov

A Study of STAR-0310 in Healthy Adult Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Healthy Participants
Interventions
DRUG

STAR-0310

STAR-0310 will be administered as a subcutaneous bolus injection.

DRUG

Placebo

Placebo will be administered as a subcutaneous bolus injection.

Trial Locations (1)

78744

RECRUITING

Austin Clinical Research Unit - Early Clinical Development, Austin

Sponsors
All Listed Sponsors
lead

Astria Therapeutics, Inc.

INDUSTRY

NCT06782477 - A Study of STAR-0310 in Healthy Adult Participants | Biotech Hunter | Biotech Hunter